Haipeng Guo

1.8k total citations
58 papers, 1.4k citations indexed

About

Haipeng Guo is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Haipeng Guo has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Cardiology and Cardiovascular Medicine and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Haipeng Guo's work include Signaling Pathways in Disease (8 papers), Cardiac Fibrosis and Remodeling (7 papers) and Pulmonary Hypertension Research and Treatments (5 papers). Haipeng Guo is often cited by papers focused on Signaling Pathways in Disease (8 papers), Cardiac Fibrosis and Remodeling (7 papers) and Pulmonary Hypertension Research and Treatments (5 papers). Haipeng Guo collaborates with scholars based in China, United States and Thailand. Haipeng Guo's co-authors include Heng Zhou, Wei Deng, Qizhu Tang, Xin Xu, Yingjie Chen, Zhongbing Lu, Dawei Wu, Dachun Xu, Hao Wang and John Fassett and has published in prestigious journals such as Nature Communications, PLoS ONE and Circulation Research.

In The Last Decade

Haipeng Guo

57 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haipeng Guo China 23 551 361 218 195 189 58 1.4k
Karl Stangl Germany 22 606 1.1× 606 1.7× 145 0.7× 201 1.0× 152 0.8× 73 2.0k
Pingzhen Yang China 21 585 1.1× 242 0.7× 120 0.6× 140 0.7× 265 1.4× 55 1.3k
Hai‐Han Liao China 23 666 1.2× 434 1.2× 102 0.5× 153 0.8× 198 1.0× 42 1.4k
Xiaomei Guo China 24 892 1.6× 379 1.0× 202 0.9× 277 1.4× 166 0.9× 69 1.8k
Haixia Xu China 23 809 1.5× 250 0.7× 210 1.0× 137 0.7× 379 2.0× 63 1.7k
Peng Yu China 22 434 0.8× 285 0.8× 180 0.8× 146 0.7× 89 0.5× 83 1.3k
Vijayakumar Sukumaran Japan 26 736 1.3× 468 1.3× 83 0.4× 220 1.1× 221 1.2× 43 2.0k
Anna–Maria Kampoli Greece 11 302 0.5× 341 0.9× 115 0.5× 252 1.3× 119 0.6× 21 1.2k
Zheng Yang China 28 814 1.5× 659 1.8× 88 0.4× 172 0.9× 213 1.1× 51 1.7k
Dongqing Guo China 22 755 1.4× 345 1.0× 116 0.5× 102 0.5× 156 0.8× 47 1.3k

Countries citing papers authored by Haipeng Guo

Since Specialization
Citations

This map shows the geographic impact of Haipeng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haipeng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haipeng Guo more than expected).

Fields of papers citing papers by Haipeng Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haipeng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haipeng Guo. The network helps show where Haipeng Guo may publish in the future.

Co-authorship network of co-authors of Haipeng Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Haipeng Guo. A scholar is included among the top collaborators of Haipeng Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haipeng Guo. Haipeng Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Lichen, Qiu‐Yue Li, Yu‐Qiu Zhang, et al.. (2024). Population pharmacokinetics of daptomycin in critically ill patients receiving extracorporeal membrane oxygenation. Journal of Antimicrobial Chemotherapy. 79(7). 1697–1705. 2 indexed citations
3.
4.
Wang, Yi, Mingming Zhang, Rong Wang, et al.. (2024). Therapeutic Inhibition of LincRNA-p21 Protects Against Cardiac Hypertrophy. Circulation Research. 135(3). 434–449. 8 indexed citations
5.
Deng, Kai, Haipeng Guo, Xueying Li, et al.. (2024). Two swords combination: Smartphone-assisted ratiometric fluorescent and paper sensors for dual-mode detection of glyphosate in edible malt. Food Chemistry. 454. 139744–139744. 8 indexed citations
6.
Zhang, Xiaoyu, Xuan Wang, Ying Cao, et al.. (2023). Facile synthesis of ZnCo2O4@NiMoO4 with porous coated structures on carbon paper as stable and efficient Pt-free counter electrode materials for advanced dye-sensitized solar cells. Applied Surface Science. 616. 156461–156461. 22 indexed citations
7.
Han, Minjin, Haipeng Guo, Xiaoling Tong, et al.. (2023). Mutation Rate and Spectrum of the Silkworm in Normal and Temperature Stress Conditions. Genes. 14(3). 649–649. 2 indexed citations
8.
9.
Liu, Yuliang, Yihui Li, Xue Li, et al.. (2022). The effect of the cyclic GMP-AMP synthase-stimulator of interferon genes signaling pathway on organ inflammatory injury and fibrosis. Frontiers in Pharmacology. 13. 1033982–1033982. 6 indexed citations
10.
11.
He, Xin, Jianming Liu, Fei Gu, et al.. (2021). Cardiac CIP protein regulates dystrophic cardiomyopathy. Molecular Therapy. 30(2). 898–914. 6 indexed citations
12.
Wu, Qingqing, Wei Li, Min Zhang, et al.. (2021). Inhibition of 5-lipoxygenase is associated with downregulation of the leukotriene B4 receptor 1/ Interleukin-12p35 pathway and ameliorates sepsis-induced myocardial injury. Free Radical Biology and Medicine. 166. 348–357. 25 indexed citations
13.
Chen, Jinmiao, Qing Ma, Yan Sun, et al.. (2019). aYAP modRNA reduces cardiac inflammation and hypertrophy in a murine ischemia-reperfusion model. Life Science Alliance. 3(1). e201900424–e201900424. 40 indexed citations
14.
Yu, Hongling, et al.. (2018). Prognostic value of repeated serum kisspeptin measurements in early first trimester pregnancy: a preliminary study. Reproductive BioMedicine Online. 38(3). 465–471. 12 indexed citations
15.
Cui, Sumei, Yuqian Cui, Yuan Li, et al.. (2018). Inhibition of cardiac hypertrophy by aromadendrin through down-regulating NFAT and MAPKs pathways. Biochemical and Biophysical Research Communications. 506(4). 805–811. 18 indexed citations
16.
Zhang, Peng, Jun Li, Tingting Li, et al.. (2016). Globular CTRP9 inhibits oxLDL-induced inflammatory response in RAW 264.7 macrophages via AMPK activation. Molecular and Cellular Biochemistry. 417(1-2). 67–74. 45 indexed citations
17.
Yin, Mei, Xuezhong Liu, Xiaomei Chen, et al.. (2016). Ischemia-modified albumin is a predictor of short-term mortality in patients with severe sepsis. Journal of Critical Care. 37. 7–12. 26 indexed citations
18.
Xu, Xin, Zhongbing Lu, John Fassett, et al.. (2014). Metformin Protects Against Systolic Overload–Induced Heart Failure Independent of AMP-Activated Protein Kinase α2. Hypertension. 63(4). 723–728. 66 indexed citations
19.
Guo, Haipeng, Heng Zhou, Jing Zong, et al.. (2011). Gastrodin protects against cardiac hypertrophy and fibrosis. Molecular and Cellular Biochemistry. 359(1-2). 9–16. 61 indexed citations
20.
Yan, Ling, Qizhu Tang, Zhi‐Gang She, et al.. (2008). SOCS-1 Inhibits TNF-α-Induced Cardiomyocyte Apoptosis via ERK1/2 Pathway Activation. Inflammation. 31(3). 180–188. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karl Stangl Breakdown of academic impact, for papers by Pingzhen Yang Breakdown of academic impact, for papers by Hai‐Han Liao Breakdown of academic impact, for papers by Xiaomei Guo Breakdown of academic impact, for papers by Haixia Xu Breakdown of academic impact, for papers by Peng Yu Breakdown of academic impact, for papers by Vijayakumar Sukumaran Breakdown of academic impact, for papers by Anna–Maria Kampoli Breakdown of academic impact, for papers by Zheng Yang Breakdown of academic impact, for papers by Dongqing Guo
Rankless by CCL
2026